A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)

NCT00827918 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: MK-8998
DRUG: Comparator: Olanzapine
DRUG: Comparator: Placebo

Sponsor

Merck Sharp & Dohme LLC